Clinical Trial Update: Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in chronic coronary syndrome evaluating Ticin for treatment of coronary lesions using drug-eluting balloons is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Ticin

Snippet

Sponsor: Cardiocentro Ticino | Conditions: Chronic Coronary Syndrome | Phase 4 | Status: RECRUITING